CEFPIMIZOLE SODIUM

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C28H24N6O10S2.Na.H
Molecular Weight	692.652
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H+].[Na+].[H][C@]12SCC(C[N+]3=CC=C(CCS([O-])(=O)=O)C=C3)=C(N1C(=O)[C@H]2NC(=O)[C@@H](NC(=O)C4=C(NC=N4)C([O-])=O)C5=CC=CC=C5)C([O-])=O

InChI

InChIKey=JLUNZNNMKVKUOH-TZVBBFNXSA-M

InChI=1S/C28H26N6O10S2.Na/c35-23(18(16-4-2-1-3-5-16)31-24(36)19-20(27(38)39)30-14-29-19)32-21-25(37)34-22(28(40)41)17(13-45-26(21)34)12-33-9-6-15(7-10-33)8-11-46(42,43)44;/h1-7,9-10,14,18,21,26H,8,11-13H2,(H5-,29,30,31,32,35,36,38,39,40,41,42,43,44);/q;+1/p-1/t18-,21+,26+;/m0./s1

HIDE SMILES / InChI

Molecular Formula	Na
Molecular Weight	22.9898
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C28H24N6O10S2
Molecular Weight	668.654
Charge	-2
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Molecular Formula	H
Molecular Weight	1.0079
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6605719
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/3041630, http://www.ncbi.nlm.nih.gov/pubmed/4032736

Cefpimizole is an antibiotic of broad spectrum developed in Japan for the treatment of such conditions as uncomplicated gonorrhea and gynecologic infections. The drug was tested in clinical trials, however, its development was terminated.

Originator

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Obstetric and gynecologic infections 2 Sources: http://www.ncbi.nlm.nih.gov/pubmed/4032718	Curative		Phase II 1132	Unknown Approved Use Unknown
Uncomplicated gonorrhea 9 Sources: http://www.ncbi.nlm.nih.gov/pubmed/3041630	Curative		Phase II 1132	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Mechanism of action of AC-1370 on phagocyte functions.	1984 Jan	6703687
Comparison of cefpimizole with cefotaxime and penicillin G for treatment of uncomplicated gonorrhea.	1988 Apr-Jun	3041630

Patents

Sample Use Guides

In Vivo Use Guide

1.0 g of cefpimizole (gonorrea treatment).

Route of Administration: Intramuscular

In Vitro Use Guide

In vitro activity of cefpimizole was tested against C. diversus (MIC 0.4-12.5 ug/ml), H. influenzae (MIC 0.1-0.4 ug/ml), N. gonorrhoeae (MIC 0.1-1.6 ug/ml), Proteus mirabilis (MIC 0.2-12.5 ug/ml), Streptococcus pyogenes (MIC 0.4-3.1 ug/ml), Streptococcus bovis (MIC 1.6-3.1 ug/ml), Streptococcus mitis (MIC 0.2-3.1 ug/ml), Streptococcus agalactiae (MIC 0.8-3.1 ug/ml).

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:17:45 GMT 2023` Edited by `admin` on `Fri Dec 15 15:17:45 GMT 2023`
Record UNII	X4628IMC52
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CEFPIMIZOLE SODIUM

Official Name

English

CEFPIMIZOLE SODIUM [USAN]

Common Name

English

CEFPIMIZOLE SODIUM [JAN]

Common Name

English

1-[[(6R,7R)-2-Carboxy-7-[(R)-2-(5-carboxyimidazole-4-carboxamido)-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-4-(2-sulfoethyl)pyridinium hydroxide, inner salt, monosodium salt

Common Name

English

AJICEF

Brand Name

English

Cefpimizole sodium [WHO-DD]

Common Name

English

PYRIDINIUM, 1-((2-CARBOXY-7-(((((5-CARBOXY-1H-IMIDAZOL-4-YL)CARBONYL)AMINO)PHENYLACETYL)AMINO)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-4-(2-SULFOETHYL)-, HYDROXIDE, INNER SALT, MONOSODIUM SALT, (6R-(6.ALPHA.,7.BETA.(R*)))-

Common Name

English

U-63196E

Code

English

U-63,196E

Code

English

CEFPIMIZOLE SODIUM [MART.]

Common Name

English

CEFPIMIZOLE MONOSODIUM SALT [MI]

Common Name

English

CEFPIMIZOLE MONOSODIUM SALT

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C357